The Opportunity
“How can a European MedTech start-up with an AI-powered diagnostics platform connect with Southeast Asian investors and position itself for cross-border funding?”

A European MedTech company developing an AI-driven IVD platform for rare disease diagnosis sought to expand its visibility in the Asia-Pacific investment landscape. While the scientific and technical value of the platform was clear, the company needed strategic support to localise its investor narrative and build meaningful relationships in the region.

Our Role
Biorizon Consulting acted as a strategic connector, helping the start-up shape its regional positioning and initiate investor outreach across Singapore and Southeast Asia. We advised on messaging refinement, identified aligned investors and ecosystem partners, and facilitated warm introductions. Our support bridged scientific credibility with investor insight—ensuring that the company's innovation story resonated with local stakeholders.

The Outcome
The start-up gained greater exposure to regional investment opportunities, opened active dialogues with Southeast Asian VCs, and increased its readiness for cross-border fundraising. This case illustrates how targeted support from a science-led consultancy can unlock new growth markets and amplify early-stage traction.